# Greenwich LifeSciences, Inc. (GLSI): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Greenwich LifeSciences, Inc. (GLSI) is 7/100, ranked against 24,000+ stocks in 35 markets (Quality 23, Value 21, Momentum 32, each scored against its sector).

- StockRank: 7/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 23, Value 21, Momentum 32: each a 0-100 percentile within Healthcare.
- Position: #24,678 overall, #2,426 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 17.125 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 97K.

Source: https://moatmap.ai/stock/GLSI
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker